✦ LIBER ✦

952 MELD-SODIUM PREDICTS SURVIVAL AND DEVELOPMENT OF TYPE-1 HEPATORENAL SYNDROME IN PATIENTS WITH TYPE-2 HEPATORENAL SYNDROME

✍ Scribed by G.H. Pereira; M. Guevara; M. Pavesi; E. Solà; C. Fagundes; E. Garcia; V. Arroyo; P. Ginès

Book ID: 117380095
Publisher: Elsevier Science
Year: 2011
Tongue: English
Weight: 39 KB
Volume: 54
Category: Article
ISSN: 0168-8278
DOI: 10.1016/s0168-8278(11)60954-9

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Type 1 hepatorenal syndrome in cirrhosis

Type 1 hepatorenal syndrome in cirrhosis. Predictive factors forsurvival in patients treated with terlipressin

✍ F. Durand; I. Colle; F. Pessione; J. Bernuau; E. Barrière; D. Lebrec; D.C. Valla 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 145 KB

Advances in the pathogenesis and treatme

Advances in the pathogenesis and treatment of type-1 and type-2 hepatorenal syndrome

✍ Vicente Arroyo; Carlos Terra; Pere Ginès 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 709 KB

Long-term outcome of patients treated wi

Long-term outcome of patients treated with terlipressin for types 1 and 2 hepatorenal syndrome

✍ Adam G Testro; Sarah Wongseelashote; Peter W Angus; Paul J Gow 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 199 KB

Impact of liver transplantation on the s

Impact of liver transplantation on the survival of patients treated for hepatorenal syndrome type 1

✍ Thomas D. Boyer; Arun J. Sanyal; Guadalupe Garcia-Tsao; Frederick Regenstein; Lo 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 191 KB

The development of hepatorenal syndrome type 1 (HRS1) is associated with a poor prognosis. Liver transplantation improves this prognosis, but the degree of the improvement is unclear. Most patients receive vasoconstrictors such as terlipressin before transplantation, and this may affect the posttran

Terlipressin in patients with cirrhosis

Terlipressin in patients with cirrhosis and type 1 hepatorenal syndrome: A retrospective multicenter study

✍ Richard Moreau; Francois Durand; Thierry Poynard; Christian Duhamel; Jean-Paul C 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 715 KB

Midodrine, octreotide, albumin, and TIPS

Midodrine, octreotide, albumin, and TIPS in selected patients with cirrhosis and type 1 hepatorenal syndrome

✍ Florence Wong; Lavinia Pantea; Kenneth Sniderman 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 167 KB 👁 1 views

Hepatorenal syndrome (HRS) is a functional renal disorder complicating decompensated cirrhosis. Treatments to date, except liver transplantation, have been able to improve but not normalize renal function. The aim of this study was to determine the efficacy of transjugular intrahepatic portosystemic